The Pharmacology of Psychoactive Substances · 3 min read
Terminology
Understanding precise terminology is essential for addiction counselors. Key terms provide a common language for assessment, diagnosis, treatment planning, and professional communication.
Addiction refers to a chronic, relapsing brain disorder characterized by compulsive substance seeking and use despite harmful consequences. The term emphasizes the neurobiological changes underlying the condition and distinguishes it from physical dependence alone. Modern definitions recognize addiction as a complex interplay of genetic, developmental, environmental, and behavioral factors.
Physical dependence is a physiological state resulting from chronic substance use, characterized by tolerance and withdrawal. Physical dependence can occur without addiction (as with prescribed opioids for chronic pain) and represents the body's adaptation to the presence of a substance. It is neither necessary nor sufficient for a diagnosis of substance use disorder.
Tolerance is a pharmacological phenomenon where increasing doses of a substance are required to achieve effects previously produced by lower doses. Alternatively, tolerance manifests as markedly diminished effect with continued use of the same amount. Multiple mechanisms contribute to tolerance: pharmacokinetic tolerance (increased metabolism), pharmacodynamic tolerance (receptor downregulation), and learned tolerance (behavioral compensation).
Cross-tolerance occurs when tolerance to one substance extends to other substances in the same pharmacological class. For example, tolerance to alcohol confers tolerance to benzodiazepines and barbiturates because all act on GABA receptors. Cross-tolerance has important clinical implications for medication selection and dosing during detoxification.
Withdrawal refers to the physiological and psychological symptoms that emerge when a substance is reduced or discontinued after prolonged use. Withdrawal syndromes are generally opposite in character to the acute effects of the substance. Depressant withdrawal produces hyperexcitability, while stimulant withdrawal produces depression and fatigue. Withdrawal symptoms vary by substance and individual, and some withdrawal syndromes (alcohol, benzodiazepines, barbiturates) can be medically dangerous.
Intoxication is a reversible substance-specific syndrome caused by recent ingestion of a substance. It involves clinically significant behavioral or psychological changes attributable to the substance's effect on the central nervous system. Signs of intoxication vary by substance class and dose.
Craving refers to intense desire or urge to use a substance. Cravings can be triggered by environmental cues, emotional states, stress, or internal physiological states. Craving is now included as a diagnostic criterion in DSM-5 and represents a target for pharmacological and behavioral interventions.
Relapse is a return to substance use after a period of abstinence. Contemporary models view relapse as a process rather than an event, beginning with emotional and mental changes before behavioral relapse occurs. High-risk situations, negative emotional states, interpersonal conflict, and social pressure are common relapse precipitants.
Harm reduction is a public health approach that aims to reduce the negative consequences of substance use without requiring abstinence. Strategies include needle exchange programs, naloxone distribution, supervised consumption sites, and medication-assisted treatment. Harm reduction acknowledges that some individuals are unable or unwilling to abstain and seeks to minimize health and social harms.
Recovery is a process of change through which individuals improve their health and wellness, live self-directed lives, and strive to reach their full potential. SAMHSA identifies four major dimensions supporting recovery: health, home, purpose, and community. Recovery is individualized and may or may not include complete abstinence from all substances.
Abstinence refers to complete cessation of substance use. While abstinence is the goal of many treatment approaches, it is not universally required for recovery. Some treatment models emphasize moderation or controlled use for certain populations, though abstinence remains the standard for individuals with severe substance use disorders.
Detoxification is the process of clearing substances from the body while managing withdrawal symptoms. Medical detoxification involves pharmacological intervention to ensure safety and comfort. Detoxification addresses physical dependence but is not treatment for addiction; it is a precursor to rehabilitation.
| Term | What it means | Not the same as |
|---|---|---|
| Physical dependence | Body adapted to a drug: tolerance and withdrawal appear | Addiction (compulsive use despite harm) |
| Tolerance | Needing more of a drug for the same effect | Cross-tolerance (tolerance carrying over to a similar drug) |
| Lapse | A single, brief return to use | Relapse (return to the earlier pattern of use) |
| Detoxification | Medically managed withdrawal | Treatment for addiction (detox is only a first step) |
| Harm reduction | Lowering the damage from use without requiring abstinence | Approving of drug use |
Finished reading?
Lock it in with a quick The Pharmacology of Psychoactive Substances quiz.